LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Sirolimus | 0.04 | uM | LJP6 | 1 | L18 | 72 | hr | 1235 | 3600 | 4355 | 0.8265 | 0.8009 |
MDA-MB-231 | Sirolimus | 0.04 | uM | LJP6 | 2 | L18 | 72 | hr | 1235 | 3301 | 4277 | 0.7717 | 0.7306 |
MDA-MB-231 | Sirolimus | 0.04 | uM | LJP6 | 3 | L18 | 72 | hr | 1235 | 3482 | 4583 | 0.7597 | 0.7294 |
MDA-MB-231 | Sirolimus | 0.12 | uM | LJP6 | 1 | L17 | 72 | hr | 1235 | 3573 | 4355 | 0.8203 | 0.7934 |
MDA-MB-231 | Sirolimus | 0.12 | uM | LJP6 | 2 | L17 | 72 | hr | 1235 | 3482 | 4277 | 0.8141 | 0.7830 |
MDA-MB-231 | Sirolimus | 0.12 | uM | LJP6 | 3 | L17 | 72 | hr | 1235 | 3400 | 4583 | 0.7418 | 0.7078 |
MDA-MB-231 | Sirolimus | 0.37 | uM | LJP6 | 1 | L16 | 72 | hr | 1235 | 3589 | 4355 | 0.8239 | 0.7978 |
MDA-MB-231 | Sirolimus | 0.37 | uM | LJP6 | 2 | L16 | 72 | hr | 1235 | 3369 | 4277 | 0.7876 | 0.7504 |
MDA-MB-231 | Sirolimus | 0.37 | uM | LJP6 | 3 | L16 | 72 | hr | 1235 | 3461 | 4583 | 0.7551 | 0.7239 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 1 | L15 | 72 | hr | 1235 | 3633 | 4355 | 0.8340 | 0.8099 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 2 | L15 | 72 | hr | 1235 | 3543 | 4277 | 0.8283 | 0.8004 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 3 | L15 | 72 | hr | 1235 | 3431 | 4583 | 0.7486 | 0.7160 |
MDA-MB-231 | Sirolimus | 3.33 | uM | LJP6 | 1 | L14 | 72 | hr | 1235 | 3306 | 4355 | 0.7590 | 0.7184 |
MDA-MB-231 | Sirolimus | 3.33 | uM | LJP6 | 2 | L14 | 72 | hr | 1235 | 3177 | 4277 | 0.7428 | 0.6940 |
MDA-MB-231 | Sirolimus | 3.33 | uM | LJP6 | 3 | L14 | 72 | hr | 1235 | 3451 | 4583 | 0.7529 | 0.7213 |
MDA-MB-231 | Sirolimus | 10 | uM | LJP6 | 1 | L13 | 72 | hr | 1235 | 3357 | 4355 | 0.7707 | 0.7329 |
MDA-MB-231 | Sirolimus | 10 | uM | LJP6 | 2 | L13 | 72 | hr | 1235 | 3042 | 4277 | 0.7112 | 0.6535 |
MDA-MB-231 | Sirolimus | 10 | uM | LJP6 | 3 | L13 | 72 | hr | 1235 | 3424 | 4583 | 0.7471 | 0.7141 |
MDA-MB-231 | ZSTK474 | 0.04 | uM | LJP6 | 1 | M18 | 72 | hr | 1235 | 3601 | 4355 | 0.8267 | 0.8011 |
MDA-MB-231 | ZSTK474 | 0.04 | uM | LJP6 | 2 | M18 | 72 | hr | 1235 | 3732 | 4277 | 0.8725 | 0.8534 |
MDA-MB-231 | ZSTK474 | 0.04 | uM | LJP6 | 3 | M18 | 72 | hr | 1235 | 3709 | 4583 | 0.8092 | 0.7882 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 1 | M17 | 72 | hr | 1235 | 3509 | 4355 | 0.8056 | 0.7757 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 2 | M17 | 72 | hr | 1235 | 3492 | 4277 | 0.8164 | 0.7858 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 3 | M17 | 72 | hr | 1235 | 3566 | 4583 | 0.7780 | 0.7514 |
MDA-MB-231 | ZSTK474 | 0.37 | uM | LJP6 | 1 | M16 | 72 | hr | 1235 | 3394 | 4355 | 0.7792 | 0.7434 |